Baylor Eye Physicians and Surgeons

Houston, Texas 77030-4101

0 studies enrolling now · 10 studies all time

What they study most

Diabetic Macular Edema, Diabetic Retinopathy, Proliferative Diabetic Retinopathy, Retinitis Pigmentosa 39, Usher Syndrome, Type 2A, Vitreous Hemorrhage

Studies at this site

• Rate of Progression in USH2A-related Retinal Degeneration — Running, not enrolling
• DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME — Completed
• Anti-VEGF Treatment for Prevention of PDR/DME — Completed
• Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy — Completed
• Anti-VEGF vs. Prompt Vitrectomy for VH From PDR — Completed
• PROMINENT-Eye Ancillary Study (Protocol AD) — Stopped early
• Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema — Completed
• Treatment for CI-DME in Eyes With Very Good VA Study — Completed
• Phase II Combination Steroid and Anti-VEGF for Persistent DME — Completed
• Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) — Completed